Key result
Screening SCN1-4B in SCN5A-negative Brugada syndrome identifies 5 novel variants acting as risk factors.
Why the study?
The additional genetic diagnostic yield of variants in cardiac sodium channel β-subunits in SCN5A negative Brugada syndrome patients was unexplored.
Do variants in cardiac sodium channel β-subunits (SCN1B-SCN4B) contribute to the phenotype of SCN5A-negative Brugada syndrome patients?
Observational (n=74)
No
Do variants in cardiac sodium channel β-subunits (SCN1B-SCN4B) contribute to the phenotype of SCN5A-negative Brugada syndrome patients?
Variants in cardiac sodium channel β-subunits may act as risk factors rather than primary causes of Brugada syndrome, potentially explaining reduced penetrance and variable expressivity.
Answers are grounded in this paper and cite their sources.
Variants in β-subunits may act as risk modifiers in SCN5A-negative Brugada syndrome; leaves open their contribution to penetrance and expressivity.
BACKGROUND: Brugada syndrome (BrS) is an inheritable cardiac disease associated with syncope, malignant ventricular arrhythmias and sudden cardiac death. The largest proportion of mutations in BrS is found in the SCN5A gene encoding the α-subunit of cardiac sodium channels (Nav1.5). Causal SCN5A mutations are present in 18-30% of BrS patients. The additional genetic diagnostic yield of variants in cardiac sodium channel β-subunits in BrS patients was explored and functional studies on 3 novel candidate variants were performed. METHODS AND RESULTS: TheSCN1B-SCN4B genes were screened, which encode the 5 sodium channel β-subunits, in a SCN5A negative BrS population (n=74). Five novel variants were detected; in silico pathogenicity prediction classified 4 variants as possibly disease causing. Three variants were selected for functional study. These variants caused only limited alterations of Nav1.5 function. Next generation sequencing of a panel of 88 arrhythmia genes could not identify other major causal mutations. CONCLUSIONS: It was hypothesized that the studied variants are not the primary cause of BrS in these patients. However, because small functional effects of these β-subunit variants can be discriminated, they might contribute to the BrS phenotype and be considered a risk factor. The existence of these risk factors can give an explanation to the reduced penetrance and variable expressivity seen in this syndrome. We therefore recommend including the SCN1-4B genes in a next generation sequencing-based gene panel.
No takes yet. Share an insight, caveat, or question.
Peeters et al. (2015) conducted an observational in Brugada Syndrome (n=74). SCN1-4B gene variants vs. Wild-type was evaluated on Genetic diagnostic yield of SCN1-4B genes and functional effects of variants. Screening of SCN1-4B genes in 74 SCN5A-negative Brugada syndrome patients identified 5 novel variants, which functional studies suggest act as risk factors rather than the primary monogenic cause.
Synapse has enriched 10 related papers. Consider them for comparative context: